[STD in pregnancy]

Ann Dermatol Venereol. 2016 Nov;143(11):776-779. doi: 10.1016/j.annder.2016.09.023. Epub 2016 Oct 22.

[Article in French]

Authors

M Janier¹, N Dupin², D Vexiau-Robert³, F Pelletier⁴, R Viraben⁵, N Spenatto⁵; la section MST de la SFD

Affiliations

¹ Centre clinique et biologique des MST, hôpital Saint-Louis, 42, rue Bichat, 75010 Paris, France. Electronic address: [email protected].
² Service de dermatologie, hôpital Cochin, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France.
³ Centre clinique et biologique des MST, hôpital Saint-Louis, 42, rue Bichat, 75010 Paris, France.
⁴ Service de dermatologie, maladies sexuellement transmissibles, allergologie et explorations, hôpital Jean-Minjoz, CHRU, 2, boulevard Fleming, 25030 Besançon, France.
⁵ Pôle santé publique et médecine sociale, service de dermatologie et médecine sociale, hôpital La Grave, place Lange, TSA 60033, 31059 Toulouse cedex 9, France.

PMID: 27776816
DOI: 10.1016/j.annder.2016.09.023

No abstract available

Publication types

Practice Guideline

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Antiviral Agents / therapeutic use*
Cesarean Section
Female
Fetal Growth Retardation / etiology
Fetal Membranes, Premature Rupture / etiology
Humans
Infant, Newborn
Infant, Newborn, Diseases / drug therapy
Infant, Newborn, Diseases / microbiology
Infant, Newborn, Diseases / virology
Infectious Disease Transmission, Vertical / prevention & control*
Pregnancy
Pregnancy Complications, Infectious / drug therapy*
Pregnancy Complications, Infectious / microbiology
Pregnancy Complications, Infectious / virology
Sexually Transmitted Diseases / complications*
Sexually Transmitted Diseases / drug therapy
Sexually Transmitted Diseases / microbiology
Sexually Transmitted Diseases / virology

Substances

Anti-Bacterial Agents
Antiviral Agents